Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)

PURPOSE: Gemcitabine is the standard chemotherapy for patients with metastatic pancreatic adenocarcinoma. Although the 5-fluorouracil (5FU), folinic acid and cisplatin combination (LV5FU2-CDDP) is an option, the optimal order of the regimens must be determined. The first strategic phase III trial co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahan, Laetitia, Bonnetain, Frank, Ychou, Marc, Mitry, Emmanuel, Gasmi, Mohamed, Raoul, Jean-Luc, Cattan, Stéphane, Phelip, Jean-Marc, Hammel, Pascal, Chauffert, Bruno, Michel, Pierre, Legoux, Jean-Louis, Rougier, Philippe, Bedenne, Laurent, Seitz, Jean-François
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Pancreas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981019/
https://www.ncbi.nlm.nih.gov/pubmed/20947887
http://dx.doi.org/10.1136/gut.2010.216135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981019/
https://www.ncbi.nlm.nih.gov/pubmed/20947887
http://dx.doi.org/10.1136/gut.2010.216135

Ejemplares similares